An observational study in Myeloproliferative Neoplasm, sponsored by University Hospital, Brest. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-06-17.
Sponsored by University Hospital, Brest · Observational
Impact of monocytes on Myeloproliferative Neoplasm hematopoietic stem cell growth and differentiation in vitro
626 studies on the registry are indexed under Myeloproliferative Disorders; 109 are open to participants now.
This study's planned enrollment of 10 is below the median of 136 across 108 observational studies indexed under Myeloproliferative Disorders.
Browse Myeloproliferative Disorders studies →University Hospital, Brest is the lead sponsor of 594 studies on the registry; 135 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with MPN
Exclusion Criteria:
Proliferation and differentiation of hematopoitic stem/progenitor cells
Time frame: 2 years
Plan to share: Yes — All collected data that underlie results in a publication
Supporting information: Study protocol
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Brest